Overview
Alpha Psychiatry (AP) aims to publish studies of the scientific and clinical value, and encourages the submission of high-quality research that advances the understanding and treatment of psychiatry.
AP covers a wide range of topics related to psychiatry, basic and clinical neuroscience and behavioral sciences, including diagnostic methods, treatment techniques, and prevention strategies. The journal is interested in publishing original research that addresses important clinical questions and advances the understanding and treatment of these conditions. This may include studies on the effectiveness of different treatments, new diagnostic tools or techniques, and novel approaches to preventing or managing mental diseases.
AP publishes Original Article, Review, Editorial, Expert Opinion on Guidelines/Expert Opinion, Systematic Review, Study Protocols, Short Communication, Letter to the Editor, Debate. Conference proceedings may also be considered for publication.
The target audience of the journal includes psychiatrists, mental health workers, neuroscientists and researchers who are interested or working in all fields of medicine.
ISSN Numbers
Current Title (2021 - …)
Alpha Psychiatry
Electronic ISSN: 2757-8038
Previous Title (2000 – 2020)
Anatolian Journal of Psychiatry
Print ISSN: 1302-6631
Impact Factor
Publication Frequency: Bimonthly
Current Impact Factor: 3.5 (2024)
JCR Category Rank: Q1 in PSYCHIATRY
Journal History
2000 Anatolian Journal of Psychiatry released the inaugural issue.
2021 Anatolian Journal of Psychiatry (Print ISSN 1302-6631) changed its title to Alpha Psychiatry (Electronic ISSN 2757-8038).
2021 Alpha Psychiatry has been indexed by Science Citation Index Expanded (SCIE).
2021 Alpha Psychiatry has been indexed by PubMed (PMC).
2022 Alpha Psychiatry received its first Impact Factor 0.7.
Copyright
2025 Alpha Psychiatry (Volume 26, Issue 1) , published by IMR, has changed its Open Access publication model from the CC BY-NC license to the Creative Commons Attribution (CC BY) license. All papers published from Volume 1 to Volume 25 (2000–2024) are copyrighted by IMR Press, and available under a CC BY-NC license. Articles published beginning from Volume 26 Issue 1 (2025) are under the terms and conditions of the CC BY license.
IMR Press will insert the following note on the first page of the published text:
© Year The Author(s). Published by IMR Press. This is an open access article under the CC BY 4.0 license.
Permissions
IMR Press grants any third party the right to use the article freely, so long as its integrity is maintained and its original authors, citation details and publisher are identified.
Permission is not required to use original figures or tables for non-commercial and educational use (e.g., in a review article, or in a book that is not for sale) if the article is copyright IMR Press and are available for use under the CC BY-NC license. Please include the full journal reference and, for articles published in Volumes 1–Volumes 25 (2000–2024), include "Copyright (copyright year) IMR Press" as a copyright note.
Articles published beginning from Volume 26 Issue 1 (2024) are under the terms and conditions of the CC BY license. AP is not authorized to grant permission for material published under either license, as the authors retain copyright. However, depending on the intended use, permission may not be required at all. For details, see: Copyright & License.
Association, Institution, or Society Communications
As the official journal of the European Society for Translational Medicine (EUSTM), AP actively supports the dissemination of the Society’s significant scientific and clinical research. To this end, we are pleased to provide a dedicated platform for the publication of such works. These articles will be presented exactly as submitted by the societies, without any intervention from the journal or the editorial team. The content and format remain the sole responsibility of the authors.
If you are an association, institution, or society and wish to benefit from the opportunities offered by an official journal, please contact the Editorial Office at AP@imrpress.com for further information.